NCT05485532|Active Not Recruiting
Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients
TELE-CARDIO
Loading search results
TELE-CARDIO
Sponsor study identifier
observational
1,000
1 country
2
Study Start
January 1, 2021
Actual (reported)Primary Completion
January 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Development and validation of a telemonitoring system for high-risk cardiovascular patients. The main purpose of this study is to investigate the beneficial effect of continuous telemonitoring in patients with cardiovascular diseases in different clinical settings (hospitalized patients, ambulant patients, patients during cardiac rehabilitation,...) Beside established risk parameters such as HRV (heart rate variability) and DC (Deceleration Capacity) new risk stratification models should be established from the continuously recorded biosignals.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2021
Actual (reported)July 21, 2022
Actual (reported)August 3, 2022
Actual (reported)January 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
occurence of combination of cardiovascular mortality, stroke, myocardial infarction and hospitalization due to decompensated heart failure
from inclusion to end of study (max. 3 years)
occurence of all cause mortality
from inclusion to end of study (max. 3 years)
occurence of cardiovascular mortality
from inclusion to end of study (max. 3 years)
occurence of stroke
from inclusion to end of study (max. 3 years)
occurence of myocardial infarction
from inclusion to end of study (max. 3 years)
number of patients with hospitalization due to decompensated heart failure
from inclusion to end of study (max. 3 years)
Cardiac Autonomic Function
from inclusion to end of study (max. 3 years)
Development and validation of a telemonitoring system using smart devices
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with presence of inclusion criteria presenting at one of the participating centres.
Medizinische Universität Innsbruck, Univ.-Klinik für Innere Medizin III, Kardiologie und Angiologie
Innsbruck, Tyrol, 6020, Austria
Reha Zentrum Münster
Münster, Tyrol, 6232, Austria
First Submitted
July 21, 2022
First Posted
August 3, 2022
Study Start
January 1, 2021
Actual (reported)Primary Completion
January 2025
Estimated (date passed)Melatonin and Risk Of Cardiovascular Events And Malignant Tumors In The Elderly
Deep Learning of Retinal Photographs and Atherosclerotic Cardiovascular Disease
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
November 21, 2024
Record last verified: 2024-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: